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Areeb Zamir, MD; Angela Manglitz, DO; and Gretchen Perilli, MD
Department of Medicine, Lehigh Valley Health Network, Allentown, PA

Introduction
Hypercalcemia is a relatively common clinical condition that can
occur secondary to one of several etiologies. Among all causes, the
most common are primary hyperparathyroidism and malignancy.
Even though these two causes account for greater than 90% of
cases, the differential diagnosis when encountering hypercalcemia
should remain broad to in order to accurately diagnose and treat
this potentially lethal condition. One of the less common hormonal
abnormalities causing hypercalcaemia is an elevation in PTHrP,
parathyroid hormone related protein. The presence of PTHrP was
first identified as the cause of hypercalcemia in the setting of
malignancy. It is most associated with lung and breast cancer. The
protein, which mimics the effects of native parathyroid hormone,
is usually undetectable in healthy individuals. However, recent
studies and case reports have shown that PTHrp levels have
been measurable during pregnancy and lactation in females and
have disappeared or decreased after delivery. This phenomenon
is described as humoral hypercalcemia of pregnancy, which is a
peripartum increase in release of PTHrp by mammary and placental
tissue. Here, we present a case of a healthy 26-year-old female who
developed severe hypercalcemia after delivery and during breast
feeding secondary to elevated PTHrP.

Abstract

Summary of Conclusions

Clinical Case: A 25 year old female presented

•	Calcium is actively transported through the placenta from the mother to the fetus during pregnancy.

to the emergency department six days post-partum of
spontaneous vaginal delivery of twins at 28 and 4/7 weeks.
Her chief complaints included bilateral leg pain, weakness,
and difficulty ambulating for the previous two days. The
patient reported complaints of recent fatigue, polyuria, and
polydipsia. She was breastfeeding as well as pumping her
breast milk and reported only taking pre-natal vitamins and
occasional acetaminophen for headaches. Given her leg
pain, venous Doppler studies of the lower extremities were
ordered which revealed bilateral deep vein thromboses
(DVT). A CT of the chest was also performed that revealed
bilateral lower lobe pulmonary emboli (PE). Her calcium
level prior to delivery was noted to be normal, however,
on presentation, she had an elevated hypoalbuminemiacorrected calcium of 17.14mg/dL and an elevated ionized
calcium of 8.70 mg/dl. Her alkaline phosphatase was
slightly elevated at 184 U/L. Her remaining electrolytes
were all within normal limits. Her CT Chest did not reveal
any signs of mediastinal masses. Due to her bilateral DVT
and PE, she was started on a Heparin drip and admitted to
the hospital. The patient was started on normal saline at
300mL/hr and 200 units of Calcitonin two times per day for
her severe hypercalcemia.
Upon admission, her PTH was found to be extremely low.
Levels of Vitamin D 1,25, angiotensin converting enzyme,
vitamin A and serum urine protein electrophoresis were
obtained in the workup for non-PTH mediated causes of
hypercalcemia and all were within normal ranges. Her
PTHrP was found to be elevated to 27.0 pmol/L endorsing
a diagnosis of rare and benign Humoral Hypercalcemia of
Pregnancy.
The patient was treated with intravenous fluids, six days
of calcitonin, and one dose of pamidronate. Her calcium
normalized and she was clinically improved for discharge
after 6 days. During her hospital course, she was bridged to
Coumadin for anticoagulation secondary to her DVT and PE.
To date, the patient has been lost to outpatient follow up.

•	Most pregnant woman experience total hypocalcemia due to over 20g of calcium being provided
to the developing fetus. During delivery, the calcium transport mechanism through the placenta is
abruptly halted, which does not affect the majority of women who are total calcium depleted.
•	Common pathologies associated with hypercalcemia are Sarcoidosis, Vitamin A overdose,
Acromegaly, adrenal insufficiency, multiple myeloma, humoral hypercalcemia of malignancy, milk
alkali syndrome, primary hyperparathyroidism, and less commonly humoral hypercalcemia of
pregnancy.
•	Sarcoidosis, Vitamin A overdose, milk alkali syndrome, primary hyperparathyroidism and multiple
myeloma were definitively ruled out. Acromegaly and adrenal insufficiency were low on the
differential diagnosis list and would have been ruled out with tests at an outpatient office visit.
However, of note, the patient did not have any physical exam findings of Acromegaly. Adrenal
insufficiency was low on the differential diagnosis as the patient was not hypotensive and did not
have any sodium or potassium irregularities.
•	Humoral hypercalcemia of pregnancy is a benign and rare entity of excessive production of PTHrP
resulting in hypercalcemic crisis during pregnancy, puerperium, and lactation.
•	PTHrP is produced physiologically by placental tissues and mammary glands, during pregnancy and
lactation respectively.
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16.5 mg/dl

10.1 mg/dL

9.4 mg/dL

3.5-4/6 g/dl

3.2 g/dl

3.3 g/dL

3.9 g/dL

Corrected Calcium

8.5-10.1 mg/dl

17.14 mg/dl

10.6 mg/dL

n/a

Ionized Calcium

4.6-5.40 mg/dl

8.70 mg/dl

Phosphorus

2.3-4.6 mg/dl

2.5 mg/dl

25-120 U/L

184 U/L

Serum Calcium
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8.5-10.1 mg/dl

8.7 mg/dl
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89 U/L

14.0-72.0 pg/ml

1.7 pg/ml

PTHrP

0.0-3.4 pmol/L

27 pmol/L

Vitamin D, 25-OH

30-100 ng/mL

11 ng/mL

9-67 U/L

38 U/L

0.30-1.20 mg/L

0.39 mg/L

IFG-1

87-368 ng

101 ng/ml

SPEP

Ranges

Negative

UPEP

Ranges

Negative

Vitamin A, Retinol Free

•	Humoral hypercalcemia of pregnancy is a rare entity with no reported cases involving twin
gestation.

3.1 mg/dL

PTH

ACE level

•	Suckling is a stimulant for prolactin secretion which stimulates PTHrP production in the mammary
gland. When a large amount of PTHrP from the breast enters the blood stream it stimulates calcium
to shift from maternal bone into breast milk to supply the developing newborn. If there is an
excessive amount of PTHrP produced, this can lead to a hypercalcemic crisis during lactation.
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